Back to Health Guide
Patient Education1 min read

Adalimumab (Humira)

From the هضم DIGEST medical team · GI, liver and endoscopy · Riyadh

Adalimumab (Humira)

Overview

Adalimumab is a fully human monoclonal antibody that targets TNF-α. Unlike infliximab, it is given as a self-administered subcutaneous injection, making it more convenient for many patients. It is approved for Crohn's disease and ulcerative colitis, as well as several other inflammatory conditions.

Key Uses

1

Moderate-to-severe Crohn's disease

2

Moderate-to-severe ulcerative colitis

3

Crohn's fistulising disease

4

Patients who prefer self-injection over clinic infusion

5

Also approved for rheumatoid arthritis, psoriasis, and psoriatic arthritis

How It Works

•

Fully human antibody that binds and neutralises TNF-α

•

Induction: 160 mg at week 0, 80 mg at week 2; maintenance: 40 mg every 2 weeks

•

Self-administered subcutaneous injection (abdomen or thigh)

•

Pre-filled pens and syringes available; store in refrigerator

•

Biosimilars (Amgevita, Hyrimoz, Hadlima) are widely available

Safety & Self-Care

Screen for TB and hepatitis B before starting

Rotate injection sites to avoid skin reactions at the same spot

Take the pen out of the refrigerator 15–30 minutes before injecting to reduce discomfort

Report any signs of infection, unusual fatigue, or new skin changes

Avoid live vaccines; keep inactivated vaccines up to date

Set a recurring reminder for every 2-week injection day

Contact Your IMCC Team

Contact your IMCC team if you develop infection signs, symptoms worsen, you are planning a pregnancy, or before any procedure or vaccination.

What adalimumab is and how it is used

Adalimumab is an anti-TNF biologic, like infliximab, that blocks a protein driving inflammation. It is used for moderate to severe Crohn's disease and ulcerative colitis, and also for rheumatoid arthritis, psoriasis, uveitis and other inflammatory conditions. Unlike infliximab, it is given as an injection under the skin, which most people learn to do themselves at home with a pre-filled pen or syringe, usually every one to two weeks after a starting phase. Biosimilar versions exist. It is prescribed and monitored by a specialist.

Side effects, safety and monitoring

Common effects are redness, pain or itching at the injection site, headache and upper respiratory infections. Like other anti-TNF drugs it raises the risk of infections and can reactivate tuberculosis or hepatitis B, so you are screened before starting. Rarely it can cause serious infections, a lupus-like reaction, nerve problems or blood count changes. Tell your doctor about fever or infection before an injection, as the dose may need to be delayed. Store the pens in the refrigerator as directed, and avoid live vaccines. Regular blood tests and clinical review check that it is working and safe.

Frequently Asked Questions

What is adalimumab used for?
Moderate to severe Crohn's disease and ulcerative colitis, and also rheumatoid arthritis, psoriasis, uveitis and other inflammatory diseases.
How do you inject adalimumab?
It is injected under the skin of the thigh or abdomen with a pre-filled pen or syringe. Your nurse or doctor teaches you the technique and the schedule, which is usually every one to two weeks.
What are the side effects of adalimumab?
Injection-site reactions, headache and infections are most common. Rare serious effects include serious infections, reactivation of tuberculosis or hepatitis B, and a lupus-like reaction.
Can I take adalimumab if I have an infection?
Tell your doctor first. During an active infection the dose is often delayed until you recover.
How should adalimumab be stored?
In the refrigerator, protected from light, and not frozen. Follow the storage and travel instructions on the product leaflet.

Share this with someone who needs it:

Have questions or need a consultation?

Our GI specialists are ready to help you

Same-week appointments · WhatsApp replies during working hours